EXECUTIVE ENGAGEMENTS
OUTREACH
10472
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1256
Interactions with Platform & by Email
PARTICIPANTS
314
Unique # Participated
VALIDATIONS
76
Responses Validated*
COMPETITORS
47
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
84
PAGES
161
EDITION
8
PRICE
USD $4950
*Engagement stats are ongoing and dynamic
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Neuromodulation estimated at US$7.8 Billion in the year 2020, is projected to reach a revised size of US$17.8 Billion by 2027, growing at a CAGR of 12.4% over the analysis period 2020-2027. Deep brain stimulation, one of the segments analyzed in the report, is projected to record a 11.2% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sacral nerve stimulation segment is readjusted to a revised 12.8% CAGR for the next 7-year period.
The Neuromodulation market in the U.S. is estimated at US$2.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2027 trailing a CAGR of 12.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11% and 10.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.
In the global Vagus nerve stimulation segment, USA, Canada, Japan, China and Europe will drive the 9.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$2.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.1 Billion by the year 2027.
SELECT PLAYERS
Abbott Laboratories; Aleva Neurotherapeutics SA; Bioness Inc.; Boston Scientific Corporation; EnteroMedics, Inc.; LivaNova PLC; Medtronic PLC; NeuroPace, Inc.; Nevro Corp.
SEGMENTS
» Application (Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine, Other Applications) » Technology (Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation, Other Neurostimulators)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Neuromodulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 |
| World Current & Future Analysis for Deep brain stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Deep brain stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Sacral nerve stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Sacral nerve stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Vagus nerve stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Vagus nerve stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Spinal cord stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Spinal cord stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Transcutaneous electrical nerve stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Transcutaneous electrical nerve stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Repetitive transcranial magnetic stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Repetitive transcranial magnetic stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Other Neurostimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Other Neurostimulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Failed Back Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Failed Back Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Gastroparesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Gastroparesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027 |
| USA Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027 |
| China Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Neuromodulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027 |
| Europe Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027 |
| France Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027 |
| UK Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 47 |
The U.S. Economy is Reinventing Itself to Weather Economic Storms.
Here's An Analytical Window into the Changing Opportunities.
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com